India to Poland: Sorafenib Export Trade Route
India has recorded 19 verified shipments of Sorafenib exported to Poland, representing a combined trade value of $185.2K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $9.7K USD. The leading Indian exporter is EURO LIFECARE PRIVATE LIMITED, which accounts for 93% of total export value with 1 shipments worth $171.6K USD. On the buying side, LIMITED LIABILITY COMPANY is the largest importer in Poland with $171.6K USD in purchases. The top 3 suppliers — EURO LIFECARE PRIVATE LIMITED, LEOWIN HEALTHCARE LLP, SACRED LEAVES PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Sorafenib corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $185.2K USD. The route is dominated by EURO LIFECARE PRIVATE LIMITED, which alone accounts for roughly 93% of all export value, reflecting the consolidated nature of India's sorafenib manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $9.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with sorafenib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 11.1%, placing it at rank #12 among India's top sorafenib export destinations globally.
On the import side, key buyers of Indian sorafenib in Poland include LIMITED LIABILITY COMPANY, DM-GROUP PLANET SP Z O O SP K, TO THE ORDER............ and 8 others. LIMITED LIABILITY COMPANY is the single largest importer with 1 shipments valued at $171.6K USD.
Route Characteristics
- Average transit
